These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21277204)

  • 1. Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes.
    Conde-Frieboes K; Ankersen M; Breinholt J; Hansen BS; Raun K; Thøgersen H; Wulff BS
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1459-63. PubMed ID: 21277204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
    Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
    Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity.
    Szewczyk JR; Laudeman CP; Sammond DM; Villeneuve M; Minick DJ; Grizzle MK; Daniels AJ; Andrews JL; Ignar DM
    Bioorg Med Chem; 2010 Mar; 18(5):1822-33. PubMed ID: 20172734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.
    Guo L; Ye Z; Liu J; He S; Bakshi RK; Sebhat IK; Dobbelaar PH; Hong Q; Jian T; Dellureficio JP; Tsou NN; Ball RG; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Chen HY; Chen AS; Martin WJ; MacIntyre DE; Strack AM; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4895-900. PubMed ID: 20621473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119.
    Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE
    Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents.
    Chaki S; Ogawa S; Toda Y; Funakoshi T; Okuyama S
    Eur J Pharmacol; 2003 Aug; 474(1):95-101. PubMed ID: 12909200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2-azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonist.
    Ye Z; Guo L; Barakat KJ; Pollard PG; Palucki BL; Sebhat IK; Bakshi RK; Tang R; Kalyani RN; Vongs A; Chen AS; Chen HY; Rosenblum CI; MacNeil T; Weinberg DH; Peng Q; Tamvakopoulos C; Miller RR; Stearns RA; Cashen DE; Martin WJ; Metzger JM; Strack AM; MacIntyre DE; Van der Ploeg LH; Patchett AA; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3501-5. PubMed ID: 15982875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
    Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans.
    Lansdell MI; Hepworth D; Calabrese A; Brown AD; Blagg J; Burring DJ; Wilson P; Fradet D; Brown TB; Quinton F; Mistry N; Tang K; Mount N; Stacey P; Edmunds N; Adams C; Gaboardi S; Neal-Morgan S; Wayman C; Cole S; Phipps J; Lewis M; Verrier H; Gillon V; Feeder N; Heatherington A; Sultana S; Haughie S; Martin SW; Sudworth M; Tweedy S
    J Med Chem; 2010 Apr; 53(8):3183-97. PubMed ID: 20329799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel melanocortin4 receptor selective MSH analogues.
    Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
    Br J Pharmacol; 1998 May; 124(1):75-82. PubMed ID: 9630346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocortin activity in the amygdala influences alcohol intake.
    York DA; Boghossian S; Park-York M
    Pharmacol Biochem Behav; 2011 Mar; 98(1):112-9. PubMed ID: 21167196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine core.
    Sebhat IK; Lai Y; Barakat K; Ye Z; Tang R; Kalyani RN; Vongs A; Macneil T; Weinberg DH; Cabello MA; Maroto M; Teran A; Fong TM; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5720-3. PubMed ID: 17768046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats.
    Kask A; Rägo L; Mutulis F; Pähkla R; Wikberg JE; Schiöth HB
    Biochem Biophys Res Commun; 1998 Apr; 245(1):90-3. PubMed ID: 9535789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
    Ying Y; Lan XP; Tian YP
    Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexia.
    Joppa MA; Ling N; Chen C; Gogas KR; Foster AC; Markison S
    Peptides; 2005 Nov; 26(11):2294-301. PubMed ID: 16269355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 1-amino-4-phenylcyclohexane-1-carboxylic acid and its influence on agonist selectivity between human melanocortin-4 and -1 receptors in linear pentapeptides.
    Chu XJ; Bartkovitz D; Danho W; Swistok J; Cheung AW; Kurylko G; Rowan K; Yeon M; Franco L; Qi L; Chen L; Yagaloff K
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4910-4. PubMed ID: 16169218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.